Donal McLornan, Consultant in Haematology and Stem Cell Transplantation at UCLH, shared a post by ASH on X, adding:
“Prediction of outcomes post allo-HCT in Myelofibrosis via ML.
Practical online tool to aid the transplant decision and discussion.”
Quoting ASH‘s post:
“This tool outperformed standard models in accuracy, identifying a subset of high-risk patients with a 40% chance of dying within a year after transplant – 25% of patients with myelofibrosis. This data helps patients weigh disease-related risk factors when considering a transplant.”
